Medicinal Chemistry Aspects of Drug Targets in Sphingolipid Metabolism

Medicinal Chemistry Aspects of Drug Targets in Sphingolipid Metabolism
复制标题

鞘脂代谢中药物靶点的药物化学方面

DOI:
10.1002/cmdc.200700252
复制
发表时间:
2008
期刊:
影响因子:
3.4
通讯作者:
P. Nussbaumer
P. Nussbaumer
中科院分区:
医学4区
文献类型:
--
作者:
P. Nussbaumer

文献摘要

参考文献

被引文献

相似文献

Sphingolipids are characterised by a long-chain base (sphingoid) backbone, commonly comprising 18 to 20 carbon atoms, substituted by two to three hydroxy groups (at least at positions 1 and 3) and in most cases a trans double bond in position 4. In human cells the common backbone of the majority of sphingolipids is (2S,3R,4E)-2-amino-4-octadecene-1,3-diol, that is, d-erythro-sphingosine, whereas the saturated analogue dihydrosphingosine is present as a minor component (Figure 1). Ceramides are derivatives acylated at the amino
酸性鞘磷脂酶敲除小鼠中缺陷性 TNF-α 介导的肝细胞凋亡和肝损伤。
DOI: 10.1172/jci16010
发表时间: 2003
期刊: The Journal of clinical investigation.
影响因子: --
作者:
Garcia-Ruiz,Carmen;Colell,Anna;Mari,Montserrat;Morales,Albert;Calvo,Maria;Enrich,Carlos;Fernandez-Checa,JoseC
通讯作者: Fernandez-Checa,JoseC
DOI: --
发表时间: 2003-09
期刊: Cancer research
影响因子: 11.2
作者:
K. French;Randy S. Schrecengost;Brian D. Lee;Zhuang Yan;Staci N Smith;Justin L Eberly;Jong K. Yun
通讯作者: K. French;Randy S. Schrecengost;Brian D. Lee;Zhuang Yan;Staci N Smith;Justin L Eberly;Jong K. Yun
DOI: 10.1021/jo034828q
发表时间: 2003-08
期刊: The Journal of organic chemistry
影响因子: --
作者:
Xuequan Lu;S. Cseh;H. Byun;G. Tigyi;R. Bittman
通讯作者: Xuequan Lu;S. Cseh;H. Byun;G. Tigyi;R. Bittman
DOI: 10.1016/j.ymeth.2006.05.004
发表时间: 2006-06-01
期刊: METHODS
影响因子: 4.8
作者:
Bielawski, Jacek;Szulc, Zdzislaw M.;Bielawska, Alicja
通讯作者: Bielawska, Alicja